Table 1.

Characteristics of Patients With Suspected COVID-19 Reinfections at a Tertiary Care Center, Iowa March–December 2020

Patient	Age	Sex	Comorbidities	1st Ct Value (ORF1ab, S, and N genes) or *(N1, N2 Genes)	2nd Ct Value (ORF1ab, S-gene, N-gene)	Symptoms on Second Presentation	Time Between 1st and 2nd Tests, d	Treatment for First Episode	Treatment for Suspected Reinfection	Outcome	WGS
1	18	Female	Asthma	26* (26, 26)	28 (29, 29, 25)	Cough, sore throat, malaise	75	None	None	Recovered	No
2	19	Female	None	28 (28, 29, 28)	22 (21, 22, 23)	Headache, nasal congestion, loss of taste and smell	63	None	None	Recovered	No
3	22	Female	None	24* (24, 23)	17 (16, 17, 17)	Headache, sore throat, cough, rash, fever	72	None	None	Recovered	Yes
4	23	Female	Morbid obesity	29 (30, 29, 29)	31 (32, 31, 31)	Cough	60	None	None	Recovered	No
5	25	Female	Morbid obesity	22* (22, 21)	24 (24, 24, 23)	Rhinorrhea, cough	94	None	None	Recovered	No
6	43	Female	AML, thyroid carcinoma, bone marrow transplant, graft-vs-host disease on chronic immunosuppressive therapy, scleroderma	17 (16, 17, 17)	19 (18, 21, 19)	Cough	134	None	Bamlanivimab	Recovered	No
7	44	Male	Morbid obesity, prediabetic, OSA	38 (40, 40, 35)	25 (24, 26, 25)	Nasal congestion, cough, rash, diarrhea, malaise	92	None	None	Recovered	No

Abbreviations: AML, acute myeloid leukemia; COVID-19, coronavirus disease 2019; Ct, cycle threshold; NA, not available; OSA, obstructive sleep apnea; WGS, whole-genome sequencing.